← back to search

Wei‐Xiong Xia

Sun Yat-sen University · CN
Area of research
Otorhinolaryngology · Oncology
Research interest
Research interests include Head and Neck Cancer Studies, Lung Cancer Research Studies, Lung Cancer Treatments and Mutations, and Head and Neck Surgical Oncology.
h-index
25
citations
1,701
works
120
NIH funding
primary concept
Medicine
email

Recent publications

Efficacy and safety of cadonilimab (PD-1/CTLA-4 bispecific) in combination with chemotherapy in anti-PD-1-resistant recurrent or metastatic nasopharyngeal carcinoma: a single-arm, open-label, phase 2 trial
BMC Medicine 2025cited by 9position: middledoi
Single‐cell transcriptome analysis reveals evolving tumour microenvironment induced by immunochemotherapy in nasopharyngeal carcinoma
Clinical and Translational Medicine 2024cited by 6position: middledoi
Anti-PD1 rechallenge in combination with anti-angiogenesis or anti-EGFR treatment beyond progression in recurrent/metastatic nasopharyngeal carcinoma patients
Critical Reviews in Oncology/Hematology 2023cited by 14position: middledoi
Adjuvant Capecitabine Following Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
JAMA Oncology 2022cited by 71position: middledoi
Effect of Induction Chemotherapy With Paclitaxel, Cisplatin, and Capecitabine vs Cisplatin and Fluorouracil on Failure-Free Survival for Patients With Stage IVA to IVB Nasopharyngeal Carcinoma
JAMA Oncology 2022cited by 60position: lastdoi
Effect of Capecitabine Maintenance Therapy Plus Best Supportive Care vs Best Supportive Care Alone on Progression-Free Survival Among Patients With Newly Diagnosed Metastatic Nasopharyngeal Carcinoma Who Had Received Induction Chemotherapy
JAMA Oncology 2022cited by 46position: middledoi
Induction chemotherapy with lobaplatin and fluorouracil versus cisplatin and fluorouracil followed by chemoradiotherapy in patients with stage III–IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised, controlled, phase 3 trial
The Lancet Oncology 2021cited by 81position: middledoi
An interpretable machine learning prognostic system for locoregionally advanced nasopharyngeal carcinoma based on tumor burden features
Oral Oncology 2021cited by 40position: middledoi
Age-dependent changes of gender disparities in nasopharyngeal carcinoma survival
Biology of Sex Differences 2021cited by 36position: middledoi
Development of a self-constrained 3D DenseNet model in automatic detection and segmentation of nasopharyngeal carcinoma using magnetic resonance images
Oral Oncology 2020cited by 80position: middledoi
Development of a Prognostic Model to Identify the Suitable Definitive Radiation Therapy Candidates in de Novo Metastatic Nasopharyngeal Carcinoma: A Real-World Study
International Journal of Radiation Oncology*Biology*Physics 2020cited by 59position: middledoi
Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II–IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised phase 3 trial
The Lancet Oncology 2018cited by 149position: middledoi
Development and validation of an endoscopic images‐based deep learning model for detection with nasopharyngeal malignancies
Cancer Communications 2018cited by 82position: middledoi
The CXCL5/CXCR2 axis contributes to the epithelial-mesenchymal transition of nasopharyngeal carcinoma cells by activating ERK/GSK-3β/snail signalling
Journal of Experimental & Clinical Cancer Research 2018cited by 59position: middledoi
The prognostic significance of carcinoma-associated fibroblasts and tumor-associated macrophages in nasopharyngeal carcinoma
Cancer Management and Research 2018cited by 56position: middledoi
Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase III multicentre randomised controlled trial
European Journal of Cancer 2017cited by 283position: middledoi
Symptom clusters in patients with nasopharyngeal carcinoma during radiotherapy
European Journal of Oncology Nursing 2017cited by 45position: middledoi
Occipital lymph node metastasis from nasopharyngeal carcinoma: a special case report and literature review
Chinese Journal of Cancer 2016cited by 37position: middledoi
Positive effect of HPV status on prognostic value of blood lymphocyte-to-monocyte ratio in advanced cervical carcinoma
Cancer Cell International 2016cited by 17position: middledoi
CCL2-CCR2 axis promotes metastasis of nasopharyngeal carcinoma by activating ERK1/2-MMP2/9 pathway
Oncotarget 2015cited by 62position: middledoi
The Impact of Baseline Serum C-Reactive Protein and C-Reactive Protein Kinetics on the Prognosis of Metastatic Nasopharyngeal Carcinoma Patients Treated with Palliative Chemotherapy
PLoS ONE 2013cited by 27position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Yan‐Qun Xiang · National Sun Yat-sen University12 papers (2013–2025)Xing Lv · Central China Normal University9 papers (2015–2022)Hu L · Kunming University of Science and Technology7 papers (2015–2023)Xiang Guo · Qingdao University7 papers (2013–2022)Liang‐Ru Ke · Sun Yat-sen University6 papers (2015–2022)Guoying Liu · Sun Yat-sen University6 papers (2018–2025)Wang‐Zhong Li · University City Science Center6 papers (2018–2024)Ya‐Hui Yu · Emory University4 papers (2015–2018)Shu‐Hui Lv · Sun Yat-sen University4 papers (2020–2024)Yan‐Fang Ye · Sun Yat-sen University4 papers (2013–2025)Wei-Xin Bei · Sun Yat-sen University4 papers (2022–2025)Xiang Guo · University of Shanghai for Science and Technology4 papers (2016–2022)Chong Zhao · Peking University People's Hospital3 papers (2022–2025)Meng‐Yun Qiang · Hebei University of Engineering3 papers (2020–2021)Nian Lu · Sun Yat-sen University3 papers (2022–2025)Shu-Hui Dong · Sun Yat-sen University Cancer Center2 papers (2024–2025)Jingjing Miao · Sun Yat-sen University2 papers (2021–2022)Chenao Zhang · Sun Yat-sen University Cancer Center2 papers (2024–2025)Lin Wang · Sun Yat-sen University2 papers (2022–2025)Jing Yang · Shanxi Agricultural University2 papers (2015–2016)